Average Insider

Where insiders trade, we follow

Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ€“ Chief Financial Officer
Apr 2, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$3.39
Current$17.7682.9% above low, 17.1% below high
Sale$17.0278.7% above low, 21.3% below high
52W High$20.72
Shares
6,200
Price
$17.02
Total Value
$105,553.14

Nearby Earnings

Mar 19, 2026
EPS:Est: -1.46
Mar 23, 2026
EPS:-1.02 (est: -1.46)-29.8%
Revenue:-$209.00K

Transaction Details

InsiderSullivan Christopher Ryan
TitleChief Financial Officer
Transaction DateApr 2, 2026
Transaction CodeS Sale
Acquired/DisposedDisposed
Security
Common Stock
Direct/IndirectDirect
Filing DateApr 3, 2026
Shares Sold6,200
Price per Share$17.02
Total Value$105,553.14
Shares Owned After19,118
DerivativeNo
Accession Number0001810417-26-000006
DocumentView SEC Filing
Version: v26.3.33